Rigel Pharmaceuticals (RIGL) Posts Wider than Expected Q4 Loss of 36c/Share

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q4 EPS of ($0.36), $0.08 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• UBS Reiterates Buy Rating on Hasbro (HAS) on FY Upside Potential Despite Unchanged Guide
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight